Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Sophia Antipolis, 4 February 2014. A report published today provides strong evidence that the symptoms of depressive disorder are causally associated with the risk of coronary heart disease, and as such should be considered a potentially modifiable risk factor for the occurrence of CHD.
The findings, from the Whitehall II study of more than 10,000 civil servants in the UK, are published in the European Journal of Preventive Cardiology.(1)
Findings from former studies on the association of depression with cardiovascular diseases are described by the investigators as "heterogeneous", with associations ranging from nil to strong. Among their explanations for the inconclusive results are bias because of "reverse causation" (by which vascular disease is the origin of the depression, not the consequence), and variability in the accuracy of "depressive symptoms" in previous studies. They thus write:
"With repeated exposure measurements over a long period of adult life, causal inference would be strengthened if (a) reverse causation was excluded as an explanation for the link between depressive disorder and vascular events, and (b) a dose–response effect was evident."
Both tests were applied in this study.
The Whitehall II study began in 1985-88 when the health of 10,308 civil servants working in 20 London-based departments was assessed by clinical examination and the 30-item General Health Questionnaire. Subsequent assessments were made every two-to-three years, with "exposure" to depression measured on six occasions over the 20-year study period. All participants were followed for major CHD events and stroke.
Results over the five-year observation cycles showed a cumulative effect of depressive symptoms on the risk of CHD consistent with an increasing dose-response. Thus, there was no added risk of CHD among those who showed evidence of depressive symptoms during one or two of the questionnaire assessments, but a 100% increase in risk in those who reported symptoms at three or four of the assessments.
However, the association of depressive symptoms with stroke was only apparent with short follow-up, suggesting that this association was an effect of reverse causation.
"In other words," said investigator Dr Eric Brunner from the Department of Epidemiology and Public Health, University College London, UK, "depressive symptoms may be a sign of imminent stroke, but are not causally related." In addition, there was no evidence over the full study period of any dose-response effect with stroke. Both these findings, said Dr Brunner, suggest that in the case of stroke the depressive symptoms are a consequence of vascular disease, not its cause.
Thus, say the authors: "This finding provides evidence supporting a causal relationship between depression and CHD, in contrast to the findings in relation to stroke."
Dr Brunner adds:
“European prevention guidelines refer to depression as a coronary risk factor, and in our study repeated episodes of depressive symptoms accounted for 10% of all CHD events in the study population. However, this figure relies on the strong assumption of a direct causal mechanism. Whether or not the association is causal, supporting individuals to recover from chronic or repeated episodes of depression has merit, particularly if the individual is then better able to reduce any vascular risk, for example by quitting smoking.”
In considering an explanation for the different effect of depression on stroke and CHD risk, Dr Brunner proposed a possible effect of blood pressure.
"Depressive symptoms have been linked with low blood pressure," he said, "and this linkage will tend to confound the association between depression and stroke.”
Blood pressure is particularly important for stroke risk, but is only one of several risk factors for CHD.
1. Brunner EJ, Shipley MJ, Britton AR, et al. Depressive disorder, coronary heart disease, and stroke: dose–response and reverse causation effects in the Whitehall II cohort study. Eur J Prevent Cardiol 2014; DOI: 10.1177/2047487314520785
* This study was partly funded by the Stroke Association (UK's Stroke Charity), whose spokesperson, Dr Madina Kara, said: "Whilst depression has been identified as a risk factor for coronary heart disease, the findings of this study showed no such link between depression and stroke. However, this research does reveal that stroke survivors are twice as likely to develop depressive symptoms."* About the European Society of CardiologyThe European Society of Cardiology (ESC) represents more than 80 000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.
* The European Journal of Preventive Cardiology is a journal of the European Society of Cardiology
* Coronary heart disease describes a condition (atherosclerosis) in which the coronary arteries (which supply oxygen-rich blood to the heart) become blocked. Modifiable risk factors for CHD include smoking, hypertension, high blood cholesterol, diabetes and physical inactivity
* More information on this press release and a PDF of the paper is available from the ESC’s press office: email@example.com
© 2017 European Society of Cardiology. All rights reserved